Mustafa Deniz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mustafa Deniz has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
- Ayşegül Seremet Keskin
Department of Infectious Diseases and Clinical Microbiology, Antalya Training and Research Hospital, University of Health Sciences, Antalya 07050, Turkey
4 shared publications - Derya Seyman
Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Antalya Training and Research Hospital, Antalya 07100, Türkiye
4 shared publications - Kübra Demi̇r Önder
University of Health Sciences Türkiye, Antalya Training and Research Hospital, Clinic of Infectious Diseases and Clinical Microbiology, Antalya, Türkiye
3 shared publications - Yusuf Ozkaraman
Department of Clinical Microbiology and Infectious Diseases, University of Health Sciences Van Training and Research Hospital, Van, Türkiye
3 shared publications - Zafer Adıguzel
Univ Hlth Sci Turkey, Antalya Training & Res Hosp, Clin Infect Dis & Clin Microbiol, Antalya, Turkiye
3 shared publications - Esra Gürbüz
Sağlık Bilimleri Üniversitesi, Van Eğitim ve Araştırma Hastanesi
2 shared publications
Latest Publications
- 3 June 2026
- Published by Springer Nature in Infection
- Vol. 54 (5) , 2397-2407
Cerebrospinal fluid lipocalin-2 and bactericidal/permeability-increasing protein in acute bacterial versus viral meningitis: a prospective study
Distinguishing acute bacterial meningitis (ABM) from acute viral meningitis (AVM) remains challenging in clinically ambiguous scenarios, particularly during early disease stages or following partial antibiotic treatment. This study aimed to evaluate the diagnostic accuracy of cerebrospinal fluid (CSF) lipocalin-2 (LCN-2) and Bactericidal/Permeability-Increasing Protein (BPI) for the rapid differentiation of ABM from AVM. In this prospective study (November 2020-October 2021), 90 adult patients were categorized into ABM, AVM, and control groups based on clinical and laboratory definitions. CSF LCN-2 and BPI levels were quantified using enzyme-linked immunosorbent assay (ELISA). Group comparisons were performed using Mann-Whitney U and Kruskal-Wallis tests. Diagnostic performance was evaluated using Receiver Operating Characteristic (ROC) curve analyses to determine sensitivity, specificity, and optimal cut-off values. Analysis of a cohort of 90 patients revealed that CSF LCN-2 levels were significantly higher in the ABM group (median: 103.2 ng/mL) compared to the AVM group (median: 99.3 ng/mL; p = 0.003) and controls (p < 0.001). Applying a threshold of greater than 100.7 ng/mL, LCN-2 differentiated ABM from AVM with a sensitivity of 83.3% and a specificity of 60.0%. In contrast, CSF BPI levels did not demonstrate significant diagnostic value (p > 0.05). CSF LCN-2 demonstrated high sensitivity as a biomarker for distinguishing ABM from AVM, indicating its potential as an adjunctive tool for early clinical decision-making. In contrast, BPI did not demonstrate adequate diagnostic utility in this cohort. Further multicenter studies with larger sample sizes are necessary to confirm the clinical applicability of LCN-2.
- 3 June 2026
- Published by Springer Nature in Infection
- Vol. 54 (5) , 2397-2407
Cerebrospinal fluid lipocalin-2 and bactericidal/permeability-increasing protein in acute bacterial versus viral meningitis: a prospective study
Distinguishing acute bacterial meningitis (ABM) from acute viral meningitis (AVM) remains challenging in clinically ambiguous scenarios, particularly during early disease stages or following partial antibiotic treatment. This study aimed to evaluate the diagnostic accuracy of cerebrospinal fluid (CSF) lipocalin-2 (LCN-2) and Bactericidal/Permeability-Increasing Protein (BPI) for the rapid differentiation of ABM from AVM. In this prospective study (November 2020-October 2021), 90 adult patients were categorized into ABM, AVM, and control groups based on clinical and laboratory definitions. CSF LCN-2 and BPI levels were quantified using enzyme-linked immunosorbent assay (ELISA). Group comparisons were performed using Mann-Whitney U and Kruskal-Wallis tests. Diagnostic performance was evaluated using Receiver Operating Characteristic (ROC) curve analyses to determine sensitivity, specificity, and optimal cut-off values. Analysis of a cohort of 90 patients revealed that CSF LCN-2 levels were significantly higher in the ABM group (median: 103.2 ng/mL) compared to the AVM group (median: 99.3 ng/mL; p = 0.003) and controls (p < 0.001). Applying a threshold of greater than 100.7 ng/mL, LCN-2 differentiated ABM from AVM with a sensitivity of 83.3% and a specificity of 60.0%. In contrast, CSF BPI levels did not demonstrate significant diagnostic value (p > 0.05). CSF LCN-2 demonstrated high sensitivity as a biomarker for distinguishing ABM from AVM, indicating its potential as an adjunctive tool for early clinical decision-making. In contrast, BPI did not demonstrate adequate diagnostic utility in this cohort. Further multicenter studies with larger sample sizes are necessary to confirm the clinical applicability of LCN-2.
- Open Access
- 2 February 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (3) , 1163
Point–Prevalence of Antimicrobial–Related Potential Drug–Drug Interactions in Hospitalized Older Adults: A Multicenter Study Using Lexicomp
Background/Objectives: Potential drug–drug interaction (pDDI) refers to the co–administration of two or more drugs that interact with each other and may have therapeutic effects. Increasing rates of polypharmacy with age increase the risk of pDDIs in geriatric patients. This multicenter study aims to provide real–world data on the incidence of pDDI associated with antimicrobial therapy in hospitalized older adults. Methods: The study screened all hospitalized patients, including those aged 65 years and older. Using the Lexicomp® Drug Interaction Online Database, researchers screened for pDDIs among all medications taken by patients. Results: 663 (24.0%) aged 65 and over were included in the study. Polypharmacy was present in 64.9%, and hyperpolypharmacy was present in 10.0% of the cases. 480 (72.4%) of the cases used antimicrobial therapy. The mean total number of drugs and antimicrobials used per case was 5.86 and 1.02, respectively. A total of 372 antimicrobial–related pDDIs were detected, and at least one antimicrobial–related pDDI was identified in 202 (42%) patients receiving antimicrobials. Ciprofloxacin (73.3%), clarithromycin (58.3%), and colistin (26.3%) had the highest numbers of D–type pDDIs. The antimicrobials with the highest incidence of X–type pDDIs were metronidazole (23.6%) and clarithromycin (8.3%), respectively. The logistic analysis found a significant association between antimicrobial–related pDDIs and an increase in the number of drugs, length of hospital stays, and ID departments. Conclusions: PDDI rates associated with antimicrobials, like the high pDDI rates associated with all drugs, support the literature. Therefore, strategies should be developed to reduce the risk of pDDI when prescribing antimicrobials to geriatric patients.
- 2 February 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (3) , 1163
Open AccessPoint–Prevalence of Antimicrobial–Related Potential Drug–Drug Interactions in Hospitalized Older Adults: A Multicenter Study Using Lexicomp
Background/Objectives: Potential drug–drug interaction (pDDI) refers to the co–administration of two or more drugs that interact with each other and may have therapeutic effects. Increasing rates of polypharmacy with age increase the risk of pDDIs in geriatric patients. This multicenter study aims to provide real–world data on the incidence of pDDI associated with antimicrobial therapy in hospitalized older adults. Methods: The study screened all hospitalized patients, including those aged 65 years and older. Using the Lexicomp® Drug Interaction Online Database, researchers screened for pDDIs among all medications taken by patients. Results: 663 (24.0%) aged 65 and over were included in the study. Polypharmacy was present in 64.9%, and hyperpolypharmacy was present in 10.0% of the cases. 480 (72.4%) of the cases used antimicrobial therapy. The mean total number of drugs and antimicrobials used per case was 5.86 and 1.02, respectively. A total of 372 antimicrobial–related pDDIs were detected, and at least one antimicrobial–related pDDI was identified in 202 (42%) patients receiving antimicrobials. Ciprofloxacin (73.3%), clarithromycin (58.3%), and colistin (26.3%) had the highest numbers of D–type pDDIs. The antimicrobials with the highest incidence of X–type pDDIs were metronidazole (23.6%) and clarithromycin (8.3%), respectively. The logistic analysis found a significant association between antimicrobial–related pDDIs and an increase in the number of drugs, length of hospital stays, and ID departments. Conclusions: PDDI rates associated with antimicrobials, like the high pDDI rates associated with all drugs, support the literature. Therefore, strategies should be developed to reduce the risk of pDDI when prescribing antimicrobials to geriatric patients.
- Open Access
- 27 March 2025
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 7 (1) , 58-65
Predictors for Publication of Specialty Theses in the Field of Infectious Diseases and Clinical Microbiology
The residency program of infectious diseases and clinical microbiology (IDCM) in Türkiye was started in 1983 by adopting the name IDCM. The IDCM program in Türkiye is a five-year program, including related clinical rotations. Presenting a thesis at the end of this program is mandatory. The first specialty thesis in the field of IDCM was
- 27 March 2025
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 7 (1) , 58-65
Open AccessPredictors for Publication of Specialty Theses in the Field of Infectious Diseases and Clinical Microbiology
The residency program of infectious diseases and clinical microbiology (IDCM) in Türkiye was started in 1983 by adopting the name IDCM. The IDCM program in Türkiye is a five-year program, including related clinical rotations. Presenting a thesis at the end of this program is mandatory. The first specialty thesis in the field of IDCM was
- Open Access
- 27 September 2024
- Published by Doc Design and Informatics Co. Ltd. in Klimik Dergisi/Klimik Journal
- Vol. 37 (3) , 201-207
Infections Observed in Patients with Intravenous Drug Use
Objective: In the last decade, intravenous drug use (IVDU)-associated infections have increased significantly in parallel with the increase in intravenous drug addiction. Skin and soft tissue infections (SSTIs) and infective endocarditis (IE) are the most common infections and are important causes of morbidity and mortality. We aimed to share our experience regarding the epidemiology, microbiology, diagnosis, and management of IVDU-associated infections. Methots: Patients hospitalized with IVDU-associated bacterial infections between January 2014 and December 2023 were included in this descriptive and retrospective study. Results: Seventy-three IVDU-associated infections were identified in 66 patients. The median age was 30.5±7.23 years, and 90.9% were male; 35 (47.9%) were SSTI, 29 (39.7%) IE, 3 (4.1%) pneumonia, and one patient each (1.3%) had acute hepatitis B and brain abscess. Four (5.4%) had both SSTI and IE. Chronic hepatitis C (83.3%) was the most common viral infection. 24.2% of them had deep vein thrombosis. The leg (33.3%) and forearm (20.5%) were the most frequently affected areas in SSTI, and 19 (48.7%) were abscesses, 14 (35.9%) cellulitis, 5 (12.8%) necrotizing SSTIs and one septic arthritis. Osteomyelitis was observed in 8 (20.5%) of the SSTIs. Half (51.2%) of the SSTI patients underwent surgical intervention. Blood cultures were taken from 82% (n=32) of 39 SSTIs, and bacteremia was detected in 37.5% (n=12). Microorganisms were identified in 84% (n=21) of 25 abscesses; four were polymicrobial. Of 33 IE patients, 84.8% had right-sided IE. The tricuspid valve (96.4%) was most commonly involved; septic pulmonary embolism was documented in 20 (71.4%) of the patients. Valve surgery was performed in nine of the patients (27.2%). Methicillin susceptible Staphylococcus aureus was the most common pathogen (35.7%), followed by methicillin-resistant S. aureus (22.8%). The mortality rate was 9%. Conclusion: Increase in IVDU is an urgent public problem for our country. Multidisciplinary approach and antimicrobial treatment are essential in the treatment of IVDU associated-SSTI and IE.
- 27 September 2024
- Published by Doc Design and Informatics Co. Ltd. in Klimik Dergisi/Klimik Journal
- Vol. 37 (3) , 201-207
Open AccessInfections Observed in Patients with Intravenous Drug Use
Objective: In the last decade, intravenous drug use (IVDU)-associated infections have increased significantly in parallel with the increase in intravenous drug addiction. Skin and soft tissue infections (SSTIs) and infective endocarditis (IE) are the most common infections and are important causes of morbidity and mortality. We aimed to share our experience regarding the epidemiology, microbiology, diagnosis, and management of IVDU-associated infections. Methots: Patients hospitalized with IVDU-associated bacterial infections between January 2014 and December 2023 were included in this descriptive and retrospective study. Results: Seventy-three IVDU-associated infections were identified in 66 patients. The median age was 30.5±7.23 years, and 90.9% were male; 35 (47.9%) were SSTI, 29 (39.7%) IE, 3 (4.1%) pneumonia, and one patient each (1.3%) had acute hepatitis B and brain abscess. Four (5.4%) had both SSTI and IE. Chronic hepatitis C (83.3%) was the most common viral infection. 24.2% of them had deep vein thrombosis. The leg (33.3%) and forearm (20.5%) were the most frequently affected areas in SSTI, and 19 (48.7%) were abscesses, 14 (35.9%) cellulitis, 5 (12.8%) necrotizing SSTIs and one septic arthritis. Osteomyelitis was observed in 8 (20.5%) of the SSTIs. Half (51.2%) of the SSTI patients underwent surgical intervention. Blood cultures were taken from 82% (n=32) of 39 SSTIs, and bacteremia was detected in 37.5% (n=12). Microorganisms were identified in 84% (n=21) of 25 abscesses; four were polymicrobial. Of 33 IE patients, 84.8% had right-sided IE. The tricuspid valve (96.4%) was most commonly involved; septic pulmonary embolism was documented in 20 (71.4%) of the patients. Valve surgery was performed in nine of the patients (27.2%). Methicillin susceptible Staphylococcus aureus was the most common pathogen (35.7%), followed by methicillin-resistant S. aureus (22.8%). The mortality rate was 9%. Conclusion: Increase in IVDU is an urgent public problem for our country. Multidisciplinary approach and antimicrobial treatment are essential in the treatment of IVDU associated-SSTI and IE.
- Open Access
- 29 December 2023
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 5 (4) , 376-379
Clinical Entity Mimicking Infectious Cellulitis: Eosinophilic Cellulitis (Wells’ Syndrome)
Eosinophilic cellulitis (EC) is a rare inflammatory skin condition with fewer than 200 documented cases in the medical literature. There are only a limited number of case reports available from our country. The prevalence and incidence of EC are unknown. The disease is characterized by pruritic, non-purulent, erythematous plaques (...)
- 29 December 2023
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 5 (4) , 376-379
Open AccessClinical Entity Mimicking Infectious Cellulitis: Eosinophilic Cellulitis (Wells’ Syndrome)
Eosinophilic cellulitis (EC) is a rare inflammatory skin condition with fewer than 200 documented cases in the medical literature. There are only a limited number of case reports available from our country. The prevalence and incidence of EC are unknown. The disease is characterized by pruritic, non-purulent, erythematous plaques (...)
- Open Access
- 1 December 2022
- Published by Doc Design and Informatics Co. Ltd. in Klimik Dergisi/Klimik Journal
- Vol. 35 (4) , 263-266
Vector-Borne Endemic Viral Infection in Antalya Region: Sandfly Fever
Objective: Sandfly fever (SF) is a self-limited vector-related viral infection caused by the SF virus and is spread by phlebotomine sandflies (PSF). Fever, headache, myalgia, arthralgia, loss of appetite, weakness, nausea, and vomiting are the most common symptoms. Laboratory findings include leukopenia, thrombocytopenia, and elevated liver trans-aminase enzymes. We aimed to examine the demographic, clinical, and laboratory data of patients who were followed with SF diagnosis.Methods: Patients who were followed with SF diagnosis in our hospital between January 2011 and December 2018 were included. The data were obtained retrospectively.Results: A total of 64 patients were included in the study. The mean age was 33.1 +/- 9.7(min:19-max:58) years and 35(54.7%) of them were male. Although 53.1% had a history of contact with PSF, 92.2% had a bite mark. 91.6% of the patients were living on the ground and first floor. Fever was the most common symptom in 95.3% of the patients; 89% had myalgia-weakness, 79.6% had a headache, and 50% had a conjunctival rash. Increased transaminase enzyme levels were observed in approximately 93% of the patients. The average of ALT and AST were 284.7 U/L and 243.5 U/L, re-spectively. Leukopenia was observed in 79.6% (51/64) of them, and thrombocytopenia in 78% (50/64). CK elevation was 54% ratio (35/64). Samples were tested from 19 patients for the serological diagnosis of SF. IgM was positive in 15 (78.9%) of 19 patients and negative in 4(21%) patients. IgG was positive in 10 (52.6%) of 19 patients. Both IgG and IgM were positive in 9 patients. Only IgG positivity was detected in one patient. Conclusion: SF should be considered in patients presenting with complaints such as fever, headache, muscle joint pain, nausea-vomiting, redness in the eyes, leukopenia, thrombocytopenia, elevated transaminase enzyme, CK level, and living in or having a history of travel to subtropical regions, especially during the summer season and a history of PSF contact.
- 1 December 2022
- Published by Doc Design and Informatics Co. Ltd. in Klimik Dergisi/Klimik Journal
- Vol. 35 (4) , 263-266
Open AccessVector-Borne Endemic Viral Infection in Antalya Region: Sandfly Fever
Objective: Sandfly fever (SF) is a self-limited vector-related viral infection caused by the SF virus and is spread by phlebotomine sandflies (PSF). Fever, headache, myalgia, arthralgia, loss of appetite, weakness, nausea, and vomiting are the most common symptoms. Laboratory findings include leukopenia, thrombocytopenia, and elevated liver trans-aminase enzymes. We aimed to examine the demographic, clinical, and laboratory data of patients who were followed with SF diagnosis.Methods: Patients who were followed with SF diagnosis in our hospital between January 2011 and December 2018 were included. The data were obtained retrospectively.Results: A total of 64 patients were included in the study. The mean age was 33.1 +/- 9.7(min:19-max:58) years and 35(54.7%) of them were male. Although 53.1% had a history of contact with PSF, 92.2% had a bite mark. 91.6% of the patients were living on the ground and first floor. Fever was the most common symptom in 95.3% of the patients; 89% had myalgia-weakness, 79.6% had a headache, and 50% had a conjunctival rash. Increased transaminase enzyme levels were observed in approximately 93% of the patients. The average of ALT and AST were 284.7 U/L and 243.5 U/L, re-spectively. Leukopenia was observed in 79.6% (51/64) of them, and thrombocytopenia in 78% (50/64). CK elevation was 54% ratio (35/64). Samples were tested from 19 patients for the serological diagnosis of SF. IgM was positive in 15 (78.9%) of 19 patients and negative in 4(21%) patients. IgG was positive in 10 (52.6%) of 19 patients. Both IgG and IgM were positive in 9 patients. Only IgG positivity was detected in one patient. Conclusion: SF should be considered in patients presenting with complaints such as fever, headache, muscle joint pain, nausea-vomiting, redness in the eyes, leukopenia, thrombocytopenia, elevated transaminase enzyme, CK level, and living in or having a history of travel to subtropical regions, especially during the summer season and a history of PSF contact.
- 22 May 2022
- Published by Akdeniz University in Akdeniz Medical Journal
The effect of intubation type and place of intubation on the development of ventilator-associated pneumonia
Amaç: Çalışmamızda entübasyon türünün (elektif veya acil) ve entübasyonun yapıldığı ortamın, ventilatör ilişkili pnömoni (VİP) gelişimi üzerine etkisinin incelenmesi amaçlanmıştır. Yöntem: 1 Şubat 2019 ve 28 Şubat 2020 tarihleri arasında VİP tanısı almış, erişkin hastalar çalışmaya alındı. Yatış nedeni, entübasyon türü (elektif, acil), entübasyonun yapıldığı yer (ambulans, acil servis, yatan hasta servisi, yoğun bakım, ameliyathane), VİP gelişene kadar geçen süre ve mortalite durumları retrospektif olarak incelendi. Bulgular: Çalışmaya 180 VİP tanılı hasta dahil edildi. Hastaların %55’ ine acil entübasyon, %45’ ine elektif entübasyon yapıldığı saptandı. Entübasyon sonrası VİP gelişimine kadar geçen ortalama süre 7,9 ± 5,9 gündü. Acil entübasyonlarda VİP gelişimine kadar geçen süre elektif entübasyonlara göre daha kısa idi (sırasıyla 6.8± 4.58 vs 9.1± 7.09 gün, p=0.023). Hastaların %33.9’unun yoğun bakımda, %26.7’ sının acil serviste, %17.2’sinin ameliyat öncesinde, %11.7’sinin yatan hasta servisinde ve %10.6’sının hastaneye getirilmeden önce entübe edildiği görüldü. 7 gün mortalite %20, 14 gün mortalite %36.7, 30 gün mortalite %46.7 olarak saptandı. Kaba mortalite ve entübasyonun yapıldığı yer arasında istatiksel anlamlı ilişki saptanmadı (p=0.366). Acil entübasyon yapılan hastalarda VİP sonrası 7, 14 ve 30 gün mortalite oranlarının elektif entübasyona göre daha fazla olduğu saptandı. Sonuç: Acil entübasyonlarda elektiflere göre VİP gelişme süresinin daha kısa olduğu (p=0,009) ve tüm nedenlere bağlı mortalitenin istatistiksel anlamlı fark olmasa da acil entübasyon yapılanlarda elektif entübasyon yapılanlara göre daha fazla olduğu saptandı. Enfeksiyon kontrol önlemlerinin acil entübasyonlarda tam uygulanamamasının bu sonuca neden olduğu düşünüldü.
- 22 May 2022
- Published by Akdeniz University in Akdeniz Medical Journal
The effect of intubation type and place of intubation on the development of ventilator-associated pneumonia
Amaç: Çalışmamızda entübasyon türünün (elektif veya acil) ve entübasyonun yapıldığı ortamın, ventilatör ilişkili pnömoni (VİP) gelişimi üzerine etkisinin incelenmesi amaçlanmıştır. Yöntem: 1 Şubat 2019 ve 28 Şubat 2020 tarihleri arasında VİP tanısı almış, erişkin hastalar çalışmaya alındı. Yatış nedeni, entübasyon türü (elektif, acil), entübasyonun yapıldığı yer (ambulans, acil servis, yatan hasta servisi, yoğun bakım, ameliyathane), VİP gelişene kadar geçen süre ve mortalite durumları retrospektif olarak incelendi. Bulgular: Çalışmaya 180 VİP tanılı hasta dahil edildi. Hastaların %55’ ine acil entübasyon, %45’ ine elektif entübasyon yapıldığı saptandı. Entübasyon sonrası VİP gelişimine kadar geçen ortalama süre 7,9 ± 5,9 gündü. Acil entübasyonlarda VİP gelişimine kadar geçen süre elektif entübasyonlara göre daha kısa idi (sırasıyla 6.8± 4.58 vs 9.1± 7.09 gün, p=0.023). Hastaların %33.9’unun yoğun bakımda, %26.7’ sının acil serviste, %17.2’sinin ameliyat öncesinde, %11.7’sinin yatan hasta servisinde ve %10.6’sının hastaneye getirilmeden önce entübe edildiği görüldü. 7 gün mortalite %20, 14 gün mortalite %36.7, 30 gün mortalite %46.7 olarak saptandı. Kaba mortalite ve entübasyonun yapıldığı yer arasında istatiksel anlamlı ilişki saptanmadı (p=0.366). Acil entübasyon yapılan hastalarda VİP sonrası 7, 14 ve 30 gün mortalite oranlarının elektif entübasyona göre daha fazla olduğu saptandı. Sonuç: Acil entübasyonlarda elektiflere göre VİP gelişme süresinin daha kısa olduğu (p=0,009) ve tüm nedenlere bağlı mortalitenin istatistiksel anlamlı fark olmasa da acil entübasyon yapılanlarda elektif entübasyon yapılanlara göre daha fazla olduğu saptandı. Enfeksiyon kontrol önlemlerinin acil entübasyonlarda tam uygulanamamasının bu sonuca neden olduğu düşünüldü.
- Open Access
- 31 January 2022
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 18 (1) , 2014732
Healthcare personnel’s attitude and coverage about tetanus vaccination in Turkey: a multicenter study
The tetanus vaccine is not routinely given to Turkish adults. Protective tetanus immunity decreases with age. Health-care personnel (HCPs), who are role models in the field of health, are a target group in order to achieve a higher rate of tetanus vaccination in the community. This study was designed to evaluate attitudes and coverage regarding tetanus vaccination among a large sample of Turkish HCPs. This cross-sectional epidemiologic study was conducted from July to August 2019. A questionnaire was sent to HCPs using social media. Of the 10,644 HCPs included in the study, 65% were female. Overall, the tetanus vaccination coverage (TVC) among HCPs was 78.5% (95% CI: 77.7%-79.3%). TVC was significantly higher among physicians [83.4% (95% CI: 82%-84.6%); p < .001] compared with all other HCPs except nurses. Older age (≥40 years) and length of professional experience were significantly correlated with TVC. Of the 8353 HCPs who received tetanus vaccines during their lifetime, 73.03% received tetanus vaccination in the past 10 years. The self-vaccination rate for protection against tetanus was 13.1%. Acute injuries (25.42%) and pregnancy (23.9%) were the most common reasons for having the tetanus vaccine. One-third (33.7%) of HCPs did not have information about whether pregnant women could receive tetanus vaccinations. This survey study provided excellent baseline information about HCPs’ coverage rates and attitudes regarding tetanus vaccination. The present results suggested that tetanus boosters for HCPs should be established as soon as possible, and revealed that the HCPs younger than 30 years with relatively less professional experience and all other HCPs except nurses and physicians should be identified as the target population for future intervention programs.
- 31 January 2022
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 18 (1) , 2014732
Open AccessHealthcare personnel’s attitude and coverage about tetanus vaccination in Turkey: a multicenter study
The tetanus vaccine is not routinely given to Turkish adults. Protective tetanus immunity decreases with age. Health-care personnel (HCPs), who are role models in the field of health, are a target group in order to achieve a higher rate of tetanus vaccination in the community. This study was designed to evaluate attitudes and coverage regarding tetanus vaccination among a large sample of Turkish HCPs. This cross-sectional epidemiologic study was conducted from July to August 2019. A questionnaire was sent to HCPs using social media. Of the 10,644 HCPs included in the study, 65% were female. Overall, the tetanus vaccination coverage (TVC) among HCPs was 78.5% (95% CI: 77.7%-79.3%). TVC was significantly higher among physicians [83.4% (95% CI: 82%-84.6%); p < .001] compared with all other HCPs except nurses. Older age (≥40 years) and length of professional experience were significantly correlated with TVC. Of the 8353 HCPs who received tetanus vaccines during their lifetime, 73.03% received tetanus vaccination in the past 10 years. The self-vaccination rate for protection against tetanus was 13.1%. Acute injuries (25.42%) and pregnancy (23.9%) were the most common reasons for having the tetanus vaccine. One-third (33.7%) of HCPs did not have information about whether pregnant women could receive tetanus vaccinations. This survey study provided excellent baseline information about HCPs’ coverage rates and attitudes regarding tetanus vaccination. The present results suggested that tetanus boosters for HCPs should be established as soon as possible, and revealed that the HCPs younger than 30 years with relatively less professional experience and all other HCPs except nurses and physicians should be identified as the target population for future intervention programs.
- 30 April 2021
- Published by Doc Design and Informatics Co. Ltd. in Klimik Dergisi/Klimik Journal
- Vol. 34 (1) , 50-55
Prevalence and Related Risk Factors of Non-Alcoholic Fatty Liver Disease In HIV/AIDS Patients
Objective: Non-alcoholic fatty liver disease (NAFLD) is the most common cause of fatty liver without inflammatory infiltration, excessive alcohol consumption, viral hepatitis, and other liver diseases. NAFLD is a major health problem as it can lead to cirrhosis, liver cancer and mortality. In HIV-positive patients, the prevalence of NAFLD ranges from 28 to 48%. Currently, there is no information about the prevalence and related factors related to NAFLD in those with HIV infection in our country. In this study, we aimed to investigate the prevalence of NAFLD and the related factors in newly diagnosed HIV-infected patients. Methods: The demographic data and ultrasonography of 558 HIV-infected patients newly diagnosed between June 2015 and September 2019 were analyzed retrospectively. In hepatic echogenicity, fatty liver was diagnosed with hyper echogenicity of liver compared with renal cortex and diffusion. Uni- and multi-variate logistic regression analyses were applied to estimate factors associated with NAFLD. Results: Of 358 patients who met the study criteria, 118 (33%) were diagnosed as NAFLD. Obesity was found in 10.2% of the patients with NAFLD and in 3.1% of the patients without NAFLD (p=0.021). NAFLD rate was significantly higher in patients with diabetes mellitus and hypertension (p<0.05). In the multivariate analysis, age, 1 mg/dl increase in glucose and triglyceride values and 1 unit increase in ALT/AST were associated with NAFLD. Conclusions: The results highlight the importance of early recognition and management of NAFLD and traditional factors associated with NAFLD in Turkish patients with HIV infection. Additionally, precautions and treatments should be a priority in the follow-up of patients in order to ensure the reduction of liver-related morbidity and mortality, which is one of the non-AIDS causes of these newly diagnosed HIV-infected patients.
- 30 April 2021
- Published by Doc Design and Informatics Co. Ltd. in Klimik Dergisi/Klimik Journal
- Vol. 34 (1) , 50-55
Prevalence and Related Risk Factors of Non-Alcoholic Fatty Liver Disease In HIV/AIDS Patients
Objective: Non-alcoholic fatty liver disease (NAFLD) is the most common cause of fatty liver without inflammatory infiltration, excessive alcohol consumption, viral hepatitis, and other liver diseases. NAFLD is a major health problem as it can lead to cirrhosis, liver cancer and mortality. In HIV-positive patients, the prevalence of NAFLD ranges from 28 to 48%. Currently, there is no information about the prevalence and related factors related to NAFLD in those with HIV infection in our country. In this study, we aimed to investigate the prevalence of NAFLD and the related factors in newly diagnosed HIV-infected patients. Methods: The demographic data and ultrasonography of 558 HIV-infected patients newly diagnosed between June 2015 and September 2019 were analyzed retrospectively. In hepatic echogenicity, fatty liver was diagnosed with hyper echogenicity of liver compared with renal cortex and diffusion. Uni- and multi-variate logistic regression analyses were applied to estimate factors associated with NAFLD. Results: Of 358 patients who met the study criteria, 118 (33%) were diagnosed as NAFLD. Obesity was found in 10.2% of the patients with NAFLD and in 3.1% of the patients without NAFLD (p=0.021). NAFLD rate was significantly higher in patients with diabetes mellitus and hypertension (p<0.05). In the multivariate analysis, age, 1 mg/dl increase in glucose and triglyceride values and 1 unit increase in ALT/AST were associated with NAFLD. Conclusions: The results highlight the importance of early recognition and management of NAFLD and traditional factors associated with NAFLD in Turkish patients with HIV infection. Additionally, precautions and treatments should be a priority in the follow-up of patients in order to ensure the reduction of liver-related morbidity and mortality, which is one of the non-AIDS causes of these newly diagnosed HIV-infected patients.